921 results on '"Yuzefpolskaya, Melana"'
Search Results
2. Antithrombotic Strategies With Left Ventricular Assist Devices
3. Added prognostic value of visually estimated coronary artery calcium among heart transplant recipients
4. Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients
5. A comparison of quality-adjusted life years in older adults after heart transplantation versus long-term mechanical support: Findings from the SUSTAIN-IT study
6. Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing
7. Aortic Root Thrombosis in patients with HeartMate 3 left ventricular assist device support
8. Nitrite Generating and Depleting Capacity of the Oral Microbiome and Cardiometabolic Risk: Results from ORIGINS
9. Outcomes of treatment for deep left ventricular assist device infection
10. Acute right ventricular geometric change predicts outcomes in HeartMate 3 patients
11. Experimentally Induced Peripheral Venous Congestion Exacerbates Inflammation, Oxidative Stress, and Neurohormonal and Endothelial Cell Activation in Patients With Systolic Heart Failure
12. Early microbial markers of periodontal and cardiometabolic diseases in ORIGINS
13. Myocardial Recovery With HeartMate 3 Left Ventricular Assist Device: An Attainable Goal That Needs Better Precision
14. Less is better? Comparing effects of median sternotomy and thoracotomy surgical approaches for left ventricular assist device implantation on postoperative outcomes and valvulopathy
15. Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men
16. Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients
17. New system, old problem: Increased wait time for high-priority transplant candidates
18. Pulsatility and flow patterns across macro- and microcirculatory arteries of continuous-flow left ventricular assist device patients
19. Caregiver burden before heart transplantation and long-term mechanical circulatory support: Findings from the sustaining quality of life of the aged: Transplant or mechanical support (SUSTAIN-IT) study
20. Impact of preheart transplant spirometry and DLCO measurement on post-transplant pulmonary outcomes
21. Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease
22. Noninvasive Estimation of Blood Pressure in HeartMate 3 Patients
23. Abstract 17240: Preoperative Pectoralis Muscle Area Index is Associated With Increased Post-LVAD Length of Stay and 90-day Readmission
24. Abstract 12489: Sex Differences in Incidence and Outcomes of Patients With New-Onset Post-Transplant Diabetes Mellitus After Heart Transplantation
25. Comparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failure
26. The Difference Between Cystatin C– and Creatinine-Based eGFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF
27. Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events
28. Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure: The ARIC Study
29. Change in Caregiver Health-Related Quality of Life From Before to Early After Surgery: SUSTAIN-IT Study
30. Stroke epidemiology and outcomes in the modern era of left ventricular assist devices
31. CAV Trajectories Among Patients With No or Mild CAV at 10 Years Posttransplant.
32. Unplanned hospital readmissions following HeartMate 3 implantation: Readmission rates, causes, and impact on survival.
33. Effect of Left Ventricular Unloading by Pump Speed Adjustment on Myocardial Flow in Continuous-flow Left Ventricular Assist Device Patients
34. Presence of Intracardiac Thrombus at the Time of Left Ventricular Assist Device Implantation Is Associated With an Increased Risk of Stroke and Death
35. Medium-Term Outcomes of Concomitant Aortic Valve Repair in Patients with Continuous-Flow Left Ventricular Assist Device
36. Alterations in Sarcopenia Index are Associated with Inflammation, Gut and Oral Microbiota among Heart Failure, Left Ventricular Assist Device and Heart Transplant Patients.
37. Dietary nitrate intake and net nitrite-generating capacity of the oral microbiome interact to enhance cardiometabolic health: Results from the Oral Infections Glucose Intolerance and Insulin Resistance Study (ORIGINS)
38. Utility of a fusion protein T‐cell co‐stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume center
39. Capturing the Evolving Landscape of Primary Graft Dysfunction After Heart Transplantation: Will Achilles Ever Overtake the Tortoise?
40. Circulating Microbial Signatures and Cardiovascular Death in Patients With ESRD
41. Right Ventricular Pressure–Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular Failure
42. Advanced heart failure patients supported with ambulatory inotropic therapy: What defines success of therapy?
43. A right ventricular state of mind in the progression of heart failure with reduced ejection fraction: implications for left ventricular assist device therapy
44. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy
45. Carotid artery structure and hemodynamics and their association with adverse vascular events in left ventricular assist device patients
46. Temporary surgical ventricular assist device for treatment of acute myocardial infarction and refractory cardiogenic shock in the percutaneous device era
47. Pre‐operative pectoralis muscle area index is associated with biomarkers of inflammation and endotoxemia and predicts clinical outcomes after left ventricular assist device implantation: A cohort study.
48. Abstract 14090: Measures of Discrepancy Between Cystatin C and Creatinine Are Associated With Body Composition in the General Population and in Heart Failure
49. Abstract 13537: The Difference Between Cystatin C- and Creatinine-Based Kidney Function Assessment is Associated With Clinical Outcomes, Quality of Life and Frailty in Patients With Heart Failure and Reduced Ejection Fraction: Insights From PARADIGM-HF
50. Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.